Researchers reported that wastewater-based epidemiology can detect the emergence of clinically significant, drug-resistant Candida auris strains in healthcare settings. A study by Chang, Moshi, Nguyen and colleagues, published in Nature Communications (2026), describes wastewater signals that track emergence before it becomes evident through routine clinical channels. Wastewater surveillance here functions as an early warning system for resistant fungal strains, aligning with the broader push toward community and facility-level infection monitoring. For hospitals and public health labs, it offers a potentially scalable way to expand genomic and phenotypic screening where resources are constrained. Biotech stakeholders should note the implications for diagnostics and response workflows: if surveillance can reliably flag specific resistance-associated variants, downstream testing and stewardship interventions can be triggered faster.